Zealand lists on NASDAQ with $78.2M follow-on

On Aug. 9, metabolic company Zealand Pharma A/S (CSE:ZEAL; NASDAQ:ZEAL) raised $78.2 million through the sale of 4.4 million ADSs at $17.87 and listed on NASDAQ in a follow-on underwritten by Morgan ...